Jingyao Hong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jingyao Hong has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Mara A. McAdams DeMarco
Department of Surgery New York University New York New York USA
12 shared publications - Yiting Li
Department of Surgery New York University, Grossman School of Medicine and Langone Health New York New York USA
9 shared publications - Dorry Lidor Segev
Department of Surgery New York University New York New York USA
7 shared publications - Nicole M. Ali
Department of Surgery New York University, Grossman School of Medicine and Langone Health New York New York USA
6 shared publications - Aarti Mathur
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
5 shared publications Aarti Mathur
Department of Surgery Johns Hopkins University School of Medicine Baltimore Maryland USA
4 shared publications
Latest Publications
- Open Access
- 24 June 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (9) , 2114-2127
Changes in Depressive Symptoms Pre- and Post-Kidney Transplantation
Key Points: Depressive symptoms increased modestly during the first 4 years after kidney transplant but remained below the threshold for clinical depression. Post-kidney transplant Center for Epidemiologic Studies Depression scores improved in recipients with high pre-kidney transplant depressive symptoms. Clinicians should counsel patients on the potential mental health implications of kidney transplant and individualize care decisions accordingly. Background: Depressive symptoms are common in patients with ESKD and may persist after stopping dialysis because of challenges post-kidney transplant (KT) despite clinical benefits. We sought to assess changes in depressive symptoms pre- and post-KT. Methods: We leveraged a multicenter prospective cohort of 4661 adult (aged ≥18) potential KT candidates and 1215 recipients (2008–2025). Participants reported depressive symptoms via the Center for Epidemiologic Studies Depression (CES-D) scale (range 0–60, high depressive symptoms ≥16) at evaluation, KT, and post-KT. We used linear mixed-effect models to estimate post-KT trajectories of CES-D scores overall and by characteristics at KT admission. Results: Nineteen percentage of potential candidates at evaluation and 15% of recipients at admission had depressive symptoms; 46% and 38%, respectively, were non-Hispanic Black. Over the first 4 years post-KT, depressive symptoms slightly worsened (slope=0.4 points/yr, 95% confidence interval [CI], 0.3 to 0.6) but remained below the threshold for clinical depression. Post-KT, CES-D score change differed by pre-KT high depressive symptoms score (difference=−1.2 points/yr, 95% CI, −1.8 to −0.6). Specifically, post-KT depressive symptoms were 0.7 points/yr lower (95% CI, −1.2 to −0.1) among recipients with pre-KT high depressive symptoms and 0.5 points/yr higher (95% CI, 0.3 to 0.7) among those without. CES-D score change also differed by preemptive KT status (difference=−0.6 points/yr, 95% CI, −1.0 to −0.1, non-preemptive versus preemptive). Conclusions: Depressive symptoms worsened slightly over the first 4 years post-KT but remained below the threshold for clinical depression. Notably, post-KT CES-D scores decreased in recipients with high pre-KT depressive symptoms. Clinicians should discuss the mental health impact of KT with patients and tailor care decisions to individual needs.
- 24 June 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (9) , 2114-2127
Open AccessChanges in Depressive Symptoms Pre- and Post-Kidney Transplantation
Key Points: Depressive symptoms increased modestly during the first 4 years after kidney transplant but remained below the threshold for clinical depression. Post-kidney transplant Center for Epidemiologic Studies Depression scores improved in recipients with high pre-kidney transplant depressive symptoms. Clinicians should counsel patients on the potential mental health implications of kidney transplant and individualize care decisions accordingly. Background: Depressive symptoms are common in patients with ESKD and may persist after stopping dialysis because of challenges post-kidney transplant (KT) despite clinical benefits. We sought to assess changes in depressive symptoms pre- and post-KT. Methods: We leveraged a multicenter prospective cohort of 4661 adult (aged ≥18) potential KT candidates and 1215 recipients (2008–2025). Participants reported depressive symptoms via the Center for Epidemiologic Studies Depression (CES-D) scale (range 0–60, high depressive symptoms ≥16) at evaluation, KT, and post-KT. We used linear mixed-effect models to estimate post-KT trajectories of CES-D scores overall and by characteristics at KT admission. Results: Nineteen percentage of potential candidates at evaluation and 15% of recipients at admission had depressive symptoms; 46% and 38%, respectively, were non-Hispanic Black. Over the first 4 years post-KT, depressive symptoms slightly worsened (slope=0.4 points/yr, 95% confidence interval [CI], 0.3 to 0.6) but remained below the threshold for clinical depression. Post-KT, CES-D score change differed by pre-KT high depressive symptoms score (difference=−1.2 points/yr, 95% CI, −1.8 to −0.6). Specifically, post-KT depressive symptoms were 0.7 points/yr lower (95% CI, −1.2 to −0.1) among recipients with pre-KT high depressive symptoms and 0.5 points/yr higher (95% CI, 0.3 to 0.7) among those without. CES-D score change also differed by preemptive KT status (difference=−0.6 points/yr, 95% CI, −1.0 to −0.1, non-preemptive versus preemptive). Conclusions: Depressive symptoms worsened slightly over the first 4 years post-KT but remained below the threshold for clinical depression. Notably, post-KT CES-D scores decreased in recipients with high pre-KT depressive symptoms. Clinicians should discuss the mental health impact of KT with patients and tailor care decisions to individual needs.
- 30 April 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (5) , e70553
The Association Between Post‐Kidney Transplant Persistent Hyperparathyroidism and Fracture Risk: A Longitudinal Cohort Study
Introduction: Hyperparathyroidism (HPT) commonly persists following kidney transplant (KT) and can result in bone alterations. However, the association between persistent HPT post‐KT and fracture risk is not well‐understood. We sought to quantify the association between persistent HPT at 1‐year post‐KT and fracture risk among KT recipients. Methods: We leveraged a longitudinal prospective cohort of 344 adult KT recipients who underwent KT at a single institution (12/2008–07/2019). PTH levels were retroactively abstracted, and fractures after 1‐year‐post‐KT were ascertained using ICD‐9/ICD‐10 codes. Competing risk models were used to estimate the association between persistent HPT (PTH ≥ 70 pg/mL) at 1‐year post‐KT and the risk of fracture, with death treated as a competing event. Results: Among 344 KT recipients, 227 (66.0%) had persistent HPT at 1‐year post‐KT. After adjusting for confounders, HPT 1‐year after KT was associated with a 3.11‐fold increased risk of fractures (95% CI: 1.08–8.91). There were no differences in this association by age, sex, race, eGFR at 1‐year‐post‐KT, osteoporosis at KT, or dialysis vintage. Conclusion: Recipients with HPT 1‐year after KT had a significantly higher risk of fractures than those without persistent HPT. Future studies should establish standardized practice guidelines for the treatment of persistent HPT to mitigate fracture‐related morbidity and mortality.
- 30 April 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (5) , e70553
The Association Between Post‐Kidney Transplant Persistent Hyperparathyroidism and Fracture Risk: A Longitudinal Cohort Study
Introduction: Hyperparathyroidism (HPT) commonly persists following kidney transplant (KT) and can result in bone alterations. However, the association between persistent HPT post‐KT and fracture risk is not well‐understood. We sought to quantify the association between persistent HPT at 1‐year post‐KT and fracture risk among KT recipients. Methods: We leveraged a longitudinal prospective cohort of 344 adult KT recipients who underwent KT at a single institution (12/2008–07/2019). PTH levels were retroactively abstracted, and fractures after 1‐year‐post‐KT were ascertained using ICD‐9/ICD‐10 codes. Competing risk models were used to estimate the association between persistent HPT (PTH ≥ 70 pg/mL) at 1‐year post‐KT and the risk of fracture, with death treated as a competing event. Results: Among 344 KT recipients, 227 (66.0%) had persistent HPT at 1‐year post‐KT. After adjusting for confounders, HPT 1‐year after KT was associated with a 3.11‐fold increased risk of fractures (95% CI: 1.08–8.91). There were no differences in this association by age, sex, race, eGFR at 1‐year‐post‐KT, osteoporosis at KT, or dialysis vintage. Conclusion: Recipients with HPT 1‐year after KT had a significantly higher risk of fractures than those without persistent HPT. Future studies should establish standardized practice guidelines for the treatment of persistent HPT to mitigate fracture‐related morbidity and mortality.
- 21 January 2026
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (5) , 775-790
Frailty in Focus
Key Points: The clinical frailty scale has the strongest psychometric validity in kidney disease apart from the physical frailty phenotype. Existing frailty instruments have strong predictive validity for mortality and hospitalizations across kidney disease populations. Future work should test validity in younger adults, psychosocial and physiologic domains, and use of frailty instruments as screeners. Background: Frailty is a multisystem syndrome of decreased physiologic reserve with high prevalence, early incidence, and prognostic significance in kidney disease. Apart from the physical frailty phenotype (PFP), less is known regarding psychometric properties of other instruments. We critically appraise the validity and reliability of frailty instruments across the kidney disease continuum, acknowledge limitations, and highlight knowledge gaps. Methods: Following Preferred Reporting Items for Scoping Reviews guidelines, we searched PubMed, EMBASE, Cochrane, Cumulated Index in Nursing and Allied Health Literature, Web of Science, ClinicalTrials.gov, and PsycInfo from website inception through September 2024. Eligible studies applied a validated frailty instrument apart from the PFP to a kidney disease population. Results: We identified 136 articles after screening 4048 initial results. The most commonly cited instruments were the clinical frailty scale (CFS; N =56); Fatigue, Resistance, Ambulation, Illnesses, and Loss of Weight Scale ( N =30); and Edmonton frail scale ( N =16). Most studies included adults receiving hemodialysis ( N =85) and with CKD ( N =39). Median age ranges were 53–83 years. Most frailty instruments demonstrated predictive validity for mortality and hospitalizations. Concurrent validity was most frequently demonstrated between frailty and older age, female sex, greater comorbidities, and lower albumin. Seven studies reported reliability. While some instruments were feasible (CFS, Fatigue, Resistance, Ambulation, Illnesses, and Loss of Weight scale), their measurement could result in higher frailty prevalence compared with the PFP. Existing instruments do not capture the full spectrum of psychosocial and physiologic domains of frailty. Conclusions: The CFS demonstrates the strongest validity, apart from the PFP, although its use may result in higher measured frailty prevalence. Further research should test the feasibility of screening for frailty in clinical practice; the psychometric properties ( i.e ., responsiveness) of frailty instruments in younger adults, those with AKI, kidney transplant recipients, and those receiving conservative kidney management; and whether adding psychosocial and/or physiologic markers improves frailty measurement validity. Addressing these gaps will facilitate wider frailty measurement in kidney disease research and aid adoption into practice.
- 21 January 2026
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (5) , 775-790
Frailty in Focus
Key Points: The clinical frailty scale has the strongest psychometric validity in kidney disease apart from the physical frailty phenotype. Existing frailty instruments have strong predictive validity for mortality and hospitalizations across kidney disease populations. Future work should test validity in younger adults, psychosocial and physiologic domains, and use of frailty instruments as screeners. Background: Frailty is a multisystem syndrome of decreased physiologic reserve with high prevalence, early incidence, and prognostic significance in kidney disease. Apart from the physical frailty phenotype (PFP), less is known regarding psychometric properties of other instruments. We critically appraise the validity and reliability of frailty instruments across the kidney disease continuum, acknowledge limitations, and highlight knowledge gaps. Methods: Following Preferred Reporting Items for Scoping Reviews guidelines, we searched PubMed, EMBASE, Cochrane, Cumulated Index in Nursing and Allied Health Literature, Web of Science, ClinicalTrials.gov, and PsycInfo from website inception through September 2024. Eligible studies applied a validated frailty instrument apart from the PFP to a kidney disease population. Results: We identified 136 articles after screening 4048 initial results. The most commonly cited instruments were the clinical frailty scale (CFS; N =56); Fatigue, Resistance, Ambulation, Illnesses, and Loss of Weight Scale ( N =30); and Edmonton frail scale ( N =16). Most studies included adults receiving hemodialysis ( N =85) and with CKD ( N =39). Median age ranges were 53–83 years. Most frailty instruments demonstrated predictive validity for mortality and hospitalizations. Concurrent validity was most frequently demonstrated between frailty and older age, female sex, greater comorbidities, and lower albumin. Seven studies reported reliability. While some instruments were feasible (CFS, Fatigue, Resistance, Ambulation, Illnesses, and Loss of Weight scale), their measurement could result in higher frailty prevalence compared with the PFP. Existing instruments do not capture the full spectrum of psychosocial and physiologic domains of frailty. Conclusions: The CFS demonstrates the strongest validity, apart from the PFP, although its use may result in higher measured frailty prevalence. Further research should test the feasibility of screening for frailty in clinical practice; the psychometric properties ( i.e ., responsiveness) of frailty instruments in younger adults, those with AKI, kidney transplant recipients, and those receiving conservative kidney management; and whether adding psychosocial and/or physiologic markers improves frailty measurement validity. Addressing these gaps will facilitate wider frailty measurement in kidney disease research and aid adoption into practice.
- 20 November 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (11) , e70388
Physical Domains, Access to Kidney Transplantation, and Waitlist Mortality
Background: Frail kidney transplant (KT) candidates, characterized by low physical activity/function, have decreased chances of listing and increased risk of waitlist mortality. Impairments in these physical domains contribute to perceived physical burden and may exacerbate one another. Further, understanding the association of each domain individually with adverse outcomes may improve pre‐KT risk stratification. Methods: We leveraged 2708 KT candidates (age ≥ 18) from a two‐center prospective cohort study (2014–2024). We assessed physical activity (Minnesota Leisure Time Physical Activity Questionnaire), physical function (gait speed), and physical burden (10 questions from the Kidney Disease Quality of Life Short Form) at evaluation. We quantified the association of these three physical domains with listing (Cox proportional hazards) and waitlist mortality (competing risks, Harrell's C ‐statistic). Results: Among 2708 candidates, 40% had low physical activity, 16% had low physical function, and 54% had high physical burden. Candidates with impairment in these three physical domains were less likely to be listed (activity: adjusted hazard ratio [aHR] = 0.86, 95% confidence interval [CI]: 0.75–0.99; function: aHR = 0.54, 95%CI: 0.45–0.64; burden: aHR = 0.75, 95%CI: 0.67–0.83) and had a higher risk of waitlist mortality (activity: adjusted sub‐hazard ratio [aSHR] = 1.51, 95%CI: 1.11–2.04; function: aSHR = 1.83, 95%CI: 1.30–2.58; burden: aSHR = 1.40, 95%CI: 1.09–1.82). Physical burden showed the best discrimination in predicting mortality after adjustment (Harrell's C ‐statistic = 0.6899). Conclusion: Although impairment in physical activity, function, and burden was all associated with KT listing and waitlist mortality, physical burden was the strongest predictor of waitlist mortality. KT centers should consider measuring physical burden – a simple, low‐cost tool to help identify high‐risk candidates for prehabilitation.
- 20 November 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (11) , e70388
Physical Domains, Access to Kidney Transplantation, and Waitlist Mortality
Background: Frail kidney transplant (KT) candidates, characterized by low physical activity/function, have decreased chances of listing and increased risk of waitlist mortality. Impairments in these physical domains contribute to perceived physical burden and may exacerbate one another. Further, understanding the association of each domain individually with adverse outcomes may improve pre‐KT risk stratification. Methods: We leveraged 2708 KT candidates (age ≥ 18) from a two‐center prospective cohort study (2014–2024). We assessed physical activity (Minnesota Leisure Time Physical Activity Questionnaire), physical function (gait speed), and physical burden (10 questions from the Kidney Disease Quality of Life Short Form) at evaluation. We quantified the association of these three physical domains with listing (Cox proportional hazards) and waitlist mortality (competing risks, Harrell's C ‐statistic). Results: Among 2708 candidates, 40% had low physical activity, 16% had low physical function, and 54% had high physical burden. Candidates with impairment in these three physical domains were less likely to be listed (activity: adjusted hazard ratio [aHR] = 0.86, 95% confidence interval [CI]: 0.75–0.99; function: aHR = 0.54, 95%CI: 0.45–0.64; burden: aHR = 0.75, 95%CI: 0.67–0.83) and had a higher risk of waitlist mortality (activity: adjusted sub‐hazard ratio [aSHR] = 1.51, 95%CI: 1.11–2.04; function: aSHR = 1.83, 95%CI: 1.30–2.58; burden: aSHR = 1.40, 95%CI: 1.09–1.82). Physical burden showed the best discrimination in predicting mortality after adjustment (Harrell's C ‐statistic = 0.6899). Conclusion: Although impairment in physical activity, function, and burden was all associated with KT listing and waitlist mortality, physical burden was the strongest predictor of waitlist mortality. KT centers should consider measuring physical burden – a simple, low‐cost tool to help identify high‐risk candidates for prehabilitation.
- 17 November 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (11) , e70376
Ambient Air Pollution, Cognitive Impairment, and Dementia Among Older Patients Being Evaluated for Kidney Transplantation
Background: Older patients who are evaluated for kidney transplantation (KT) experience an earlier onset of cognitive impairment due to dialysis, comorbidities, and inactivity. Ambient fine particulate matter (PM 2.5 ) is a modifiable risk factor for dementia among community‐dwelling older adults. Inflammatory responses and oxidative stress caused by inactivity in older patients evaluated for KT may heighten vulnerability to PM 2.5 . Thus, the impact of PM 2.5 on dementia may be more severe in this population. Methods: We leveraged a prospective cohort (2009–2019) of older (age ≥ 50) patients evaluated for KT ( n = 2073) with Modified Mini‐Mental State Examination (3MS). We derived annual PM 2.5 from residential ZIP codes (high: PM 2.5 > 9 µg/m 3 ), quantifying its association with global cognitive function (linear regression), impairment (logistic regression), and risk of dementia (Cox proportional hazards model). We tested the interaction between PM 2.5 and dementia risk factors using a Wald test. Models were adjusted for confounders, including social determinants of health. Results: High PM 2.5 was associated with worse global cognitive function (difference = −3.00 points [3MS score], 95% CI: −3.93 to −2.07), with a stronger association among patients with low physical activity ( p [interaction] < 0.001). High PM 2.5 was associated with 1.90‐fold higher odds of global cognitive impairment (95% CI: 1.48–2.46), and 3.29‐fold higher risk of dementia (95% CI: 1.14–9.55). Conclusion: High PM 2.5 was associated with worse cognitive function among older patients evaluated for KT, particularly those with low physical activity. The association was stronger than prior findings among community‐dwelling older adults. Clinicians may counsel patients to monitor air quality. Patients in high PM 2.5 neighborhoods should discuss cognitive assessments and ways to increase physical activity with providers.
- 17 November 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (11) , e70376
Ambient Air Pollution, Cognitive Impairment, and Dementia Among Older Patients Being Evaluated for Kidney Transplantation
Background: Older patients who are evaluated for kidney transplantation (KT) experience an earlier onset of cognitive impairment due to dialysis, comorbidities, and inactivity. Ambient fine particulate matter (PM 2.5 ) is a modifiable risk factor for dementia among community‐dwelling older adults. Inflammatory responses and oxidative stress caused by inactivity in older patients evaluated for KT may heighten vulnerability to PM 2.5 . Thus, the impact of PM 2.5 on dementia may be more severe in this population. Methods: We leveraged a prospective cohort (2009–2019) of older (age ≥ 50) patients evaluated for KT ( n = 2073) with Modified Mini‐Mental State Examination (3MS). We derived annual PM 2.5 from residential ZIP codes (high: PM 2.5 > 9 µg/m 3 ), quantifying its association with global cognitive function (linear regression), impairment (logistic regression), and risk of dementia (Cox proportional hazards model). We tested the interaction between PM 2.5 and dementia risk factors using a Wald test. Models were adjusted for confounders, including social determinants of health. Results: High PM 2.5 was associated with worse global cognitive function (difference = −3.00 points [3MS score], 95% CI: −3.93 to −2.07), with a stronger association among patients with low physical activity ( p [interaction] < 0.001). High PM 2.5 was associated with 1.90‐fold higher odds of global cognitive impairment (95% CI: 1.48–2.46), and 3.29‐fold higher risk of dementia (95% CI: 1.14–9.55). Conclusion: High PM 2.5 was associated with worse cognitive function among older patients evaluated for KT, particularly those with low physical activity. The association was stronger than prior findings among community‐dwelling older adults. Clinicians may counsel patients to monitor air quality. Patients in high PM 2.5 neighborhoods should discuss cognitive assessments and ways to increase physical activity with providers.
- 15 October 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (1) , 118-129
Association of Myosteatosis and of Graft Loss after Kidney Transplantation
Key Points: Myosteatosis was associated with a higher risk of all-cause graft loss and mortality within the US cohort. Myosteatosis did not show an higher risk of death censored graft loss at both centers. Sarcopenia was not associated with a higher risk of all-cause graft loss or mortality. Background: Sarcopenia and myosteatosis are indicators of abnormal body composition (BC). Computed tomography (CT) imaging has proven to be an accurate modality for BC quantification in kidney transplantation (KT). We tested whether pre-KT CT-based BC was associated with both all-cause graft loss (ACGL) and mortality among adult recipients from two centers (Johns Hopkins Hospital [JHH] and University Medical Center Groningen [UMCG]). Methods: Patients who underwent a KT between 2003 and 2020 were followed for a median (interquartile range) follow-up of 6.4 (4.6–8.5) years at JHH and 6.3 (5.1–7.5) years at UMCG. Cox proportional hazard models were used to estimate the associations of BC with ACGL/mortality. Fine and Gray regression analysis was performed to assess the association between BC and death-censored graft loss. Before KT, 49% of recipients had sarcopenia and 66% had myosteatosis. Results: In total, 608 patients were included from JHH ( N =294) and UMCG ( N =314). Sarcopenia was not associated with post-KT outcomes. Myosteatosis was associated with a higher risk of ACGL (adjusted hazard ratio, 1.78; 95% confidence interval, 1.08 to 2.93) and mortality (adjusted hazard ratio, 2.35; 95% confidence interval, 1.27 to 4.33) at JHH but showed no significant association at UMCG after adjusting for confounders. Myosteatosis did not show a significant association with death-censored graft loss at both centers. Conclusions: Myosteatosis ascertained from existing CT scans could help identify recipients at higher risk for ACGL who may benefit most from prehabilitation.
- 15 October 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (1) , 118-129
Association of Myosteatosis and of Graft Loss after Kidney Transplantation
Key Points: Myosteatosis was associated with a higher risk of all-cause graft loss and mortality within the US cohort. Myosteatosis did not show an higher risk of death censored graft loss at both centers. Sarcopenia was not associated with a higher risk of all-cause graft loss or mortality. Background: Sarcopenia and myosteatosis are indicators of abnormal body composition (BC). Computed tomography (CT) imaging has proven to be an accurate modality for BC quantification in kidney transplantation (KT). We tested whether pre-KT CT-based BC was associated with both all-cause graft loss (ACGL) and mortality among adult recipients from two centers (Johns Hopkins Hospital [JHH] and University Medical Center Groningen [UMCG]). Methods: Patients who underwent a KT between 2003 and 2020 were followed for a median (interquartile range) follow-up of 6.4 (4.6–8.5) years at JHH and 6.3 (5.1–7.5) years at UMCG. Cox proportional hazard models were used to estimate the associations of BC with ACGL/mortality. Fine and Gray regression analysis was performed to assess the association between BC and death-censored graft loss. Before KT, 49% of recipients had sarcopenia and 66% had myosteatosis. Results: In total, 608 patients were included from JHH ( N =294) and UMCG ( N =314). Sarcopenia was not associated with post-KT outcomes. Myosteatosis was associated with a higher risk of ACGL (adjusted hazard ratio, 1.78; 95% confidence interval, 1.08 to 2.93) and mortality (adjusted hazard ratio, 2.35; 95% confidence interval, 1.27 to 4.33) at JHH but showed no significant association at UMCG after adjusting for confounders. Myosteatosis did not show a significant association with death-censored graft loss at both centers. Conclusions: Myosteatosis ascertained from existing CT scans could help identify recipients at higher risk for ACGL who may benefit most from prehabilitation.
- 23 August 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (8) , e70281
Pre‐ and Post‐Kidney Transplant Abdominal Computed Tomography‐Based Muscle Measurements and Post‐KT Outcomes
Introduction: Early post‐kidney transplant (KT) changes likely impact body composition, resulting in adverse post‐KT outcomes. We estimated post‐KT trajectories of computed tomography (CT)‐based muscle quantity/quality and tested whether they were associated with mortality and death‐censored graft loss (DCGL) among frail and nonfrail recipients. Methods: We leveraged a cohort of 294 adult KT recipients (December 2008–February 2020) with CT measurements (muscle quantity: skeletal muscle index; muscle quality: skeletal muscle radiation attenuation). We used mixed linear regression models to estimate 3‐year post‐KT muscle quantity/quality trajectories. Cox proportional hazard models quantified the association between time‐varying pre‐/post‐KT muscle mass measurements and post‐KT mortality and DCGL. Results: Muscle quantity (−2.4 cm 2 /m 2 /year) and quality (−1.3 HU/year) decreased during the first 2 years post‐KT and then remained constant in the third year post‐KT. Change in muscle quantity ( p interaction < 0.01) and quality ( p interaction = 0.01) differed by frailty in the first 2 years post‐KT; change in muscle quality ( p interaction < 0.01) differed by lower extremity impairment in the third year post‐KT. Among frail recipients, lower muscle quantity (per 10 cm 2 /m 2 ) was associated with elevated mortality risk (aHR: 2.00, 95% CI: 1.08–3.70), but not among nonfrail recipients. Among older (≥65 years) recipients, lower muscle quantity was associated with increased DCGL risk (aHR: 2.70, 95% CI: 1.04–7.04), but not among younger recipients. Lower muscle quality (per 10 HU) was associated with elevated mortality (aHR: 2.23, 95% CI: 1.61–3.08) and DCGL (aHR: 1.90, 95% CI: 1.16–3.12) risk. Conclusion: Lower pre‐/post‐KT muscle quantity/quality were associated with higher risks of post‐KT adverse outcomes. Pre‐/post‐KT rehabilitation to improve muscle quantity/quality may be an effective clinical intervention to minimize risks of adverse post‐KT outcomes.
- 23 August 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (8) , e70281
Pre‐ and Post‐Kidney Transplant Abdominal Computed Tomography‐Based Muscle Measurements and Post‐KT Outcomes
Introduction: Early post‐kidney transplant (KT) changes likely impact body composition, resulting in adverse post‐KT outcomes. We estimated post‐KT trajectories of computed tomography (CT)‐based muscle quantity/quality and tested whether they were associated with mortality and death‐censored graft loss (DCGL) among frail and nonfrail recipients. Methods: We leveraged a cohort of 294 adult KT recipients (December 2008–February 2020) with CT measurements (muscle quantity: skeletal muscle index; muscle quality: skeletal muscle radiation attenuation). We used mixed linear regression models to estimate 3‐year post‐KT muscle quantity/quality trajectories. Cox proportional hazard models quantified the association between time‐varying pre‐/post‐KT muscle mass measurements and post‐KT mortality and DCGL. Results: Muscle quantity (−2.4 cm 2 /m 2 /year) and quality (−1.3 HU/year) decreased during the first 2 years post‐KT and then remained constant in the third year post‐KT. Change in muscle quantity ( p interaction < 0.01) and quality ( p interaction = 0.01) differed by frailty in the first 2 years post‐KT; change in muscle quality ( p interaction < 0.01) differed by lower extremity impairment in the third year post‐KT. Among frail recipients, lower muscle quantity (per 10 cm 2 /m 2 ) was associated with elevated mortality risk (aHR: 2.00, 95% CI: 1.08–3.70), but not among nonfrail recipients. Among older (≥65 years) recipients, lower muscle quantity was associated with increased DCGL risk (aHR: 2.70, 95% CI: 1.04–7.04), but not among younger recipients. Lower muscle quality (per 10 HU) was associated with elevated mortality (aHR: 2.23, 95% CI: 1.61–3.08) and DCGL (aHR: 1.90, 95% CI: 1.16–3.12) risk. Conclusion: Lower pre‐/post‐KT muscle quantity/quality were associated with higher risks of post‐KT adverse outcomes. Pre‐/post‐KT rehabilitation to improve muscle quantity/quality may be an effective clinical intervention to minimize risks of adverse post‐KT outcomes.
- 3 January 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 20 (2) , 197-205
Weight Loss Intentionality and Frailty are Associated with Pre–Kidney Transplant Outcomes
Key Points: In frail kidney transplant (KT) candidates with obesity, unintentional weight loss preceding KT evaluation is associated with lower chance of listing. In frail candidates with obesity, both unintentional and intentional weight loss is associated with higher waitlist mortality. Results suggest that in frail candidates with obesity, careful supervision of weight loss prior to KT should be considered, emphasizing strategies to preserve muscle mass and function. Background: Unintentional weight loss, a hallmark of frailty, predicts worse post–kidney transplantation (KT) outcomes. However, weight loss in candidates with obesity is often recommended to enhance transplant eligibility. We tested whether pre-evaluation weight change is associated with listing/waitlist mortality, considering intentionality and frailty. Methods: We leveraged data on body mass index, weight loss intentionality (1 year before evaluation and at evaluation), and frailty (four-component Physical Frailty Phenotype at evaluation) for 1361 candidates (895 listed) with obesity (body mass index ≥30 kg/m 2 ) enrolled in a prospective multicenter cohort study. We estimated the association between pre-evaluation weight change (stable, gain, unintentional/intentional loss) with chance of listing/waitlist mortality using Cox proportional hazards/competing-risks models. Results: Among candidates with obesity, 48% had stable weight, 17% had weight gain, 16% had unintentional weight loss, and 20% had intentional weight loss over the year before evaluation. Among frail candidates with obesity, stable weight was associated with a 27% lower chance of listing (adjusted hazard ratio [aHR], 0.73; 95% confidence intervals [CI], 0.55 to 0.96), weight gain with a 47% lower chance of listing (aHR, 0.53; 95% CI, 0.34 to 0.80), and unintentional weight loss with a 48% lower chance of listing (aHR, 0.52; 95% CI, 0.32 to 0.84) compared with nonfrail candidates with stable weight. However, in frail candidates with obesity, intentional weight loss was not associated with a significantly lower chance of listing compared with nonfrail candidates with stable weight. In addition, among frail candidates with obesity, stable weight (adjusted subhazard ratio [aSHR], 1.72; 95% CI, 1.01 to 2.90), unintentional weight loss (aSHR, 2.78; 95% CI, 1.23 to 6.27), and intentional weight loss (aSHR, 2.26; 95% CI, 1.05 to 4.85) were associated with higher waitlist mortality compared with nonfrail candidates with stable weight. Among nonfrail candidates, no associations were observed for weight change and frailty status with either chance of listing or waitlist mortality. Conclusions: Among frail candidates with obesity, unintentional pre-KT weight loss is associated with a lower chance of listing; however, any weight loss is associated with higher waitlist mortality. Our findings suggest that frail candidates with obesity may benefit from clinician supervision of pre-KT weight loss.
- 3 January 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 20 (2) , 197-205
Weight Loss Intentionality and Frailty are Associated with Pre–Kidney Transplant Outcomes
Key Points: In frail kidney transplant (KT) candidates with obesity, unintentional weight loss preceding KT evaluation is associated with lower chance of listing. In frail candidates with obesity, both unintentional and intentional weight loss is associated with higher waitlist mortality. Results suggest that in frail candidates with obesity, careful supervision of weight loss prior to KT should be considered, emphasizing strategies to preserve muscle mass and function. Background: Unintentional weight loss, a hallmark of frailty, predicts worse post–kidney transplantation (KT) outcomes. However, weight loss in candidates with obesity is often recommended to enhance transplant eligibility. We tested whether pre-evaluation weight change is associated with listing/waitlist mortality, considering intentionality and frailty. Methods: We leveraged data on body mass index, weight loss intentionality (1 year before evaluation and at evaluation), and frailty (four-component Physical Frailty Phenotype at evaluation) for 1361 candidates (895 listed) with obesity (body mass index ≥30 kg/m 2 ) enrolled in a prospective multicenter cohort study. We estimated the association between pre-evaluation weight change (stable, gain, unintentional/intentional loss) with chance of listing/waitlist mortality using Cox proportional hazards/competing-risks models. Results: Among candidates with obesity, 48% had stable weight, 17% had weight gain, 16% had unintentional weight loss, and 20% had intentional weight loss over the year before evaluation. Among frail candidates with obesity, stable weight was associated with a 27% lower chance of listing (adjusted hazard ratio [aHR], 0.73; 95% confidence intervals [CI], 0.55 to 0.96), weight gain with a 47% lower chance of listing (aHR, 0.53; 95% CI, 0.34 to 0.80), and unintentional weight loss with a 48% lower chance of listing (aHR, 0.52; 95% CI, 0.32 to 0.84) compared with nonfrail candidates with stable weight. However, in frail candidates with obesity, intentional weight loss was not associated with a significantly lower chance of listing compared with nonfrail candidates with stable weight. In addition, among frail candidates with obesity, stable weight (adjusted subhazard ratio [aSHR], 1.72; 95% CI, 1.01 to 2.90), unintentional weight loss (aSHR, 2.78; 95% CI, 1.23 to 6.27), and intentional weight loss (aSHR, 2.26; 95% CI, 1.05 to 4.85) were associated with higher waitlist mortality compared with nonfrail candidates with stable weight. Among nonfrail candidates, no associations were observed for weight change and frailty status with either chance of listing or waitlist mortality. Conclusions: Among frail candidates with obesity, unintentional pre-KT weight loss is associated with a lower chance of listing; however, any weight loss is associated with higher waitlist mortality. Our findings suggest that frail candidates with obesity may benefit from clinician supervision of pre-KT weight loss.
- 5 November 2024
- Published by Wiley in Clinical Transplantation
- Vol. 38 (11) , e70018
Hospitalization and Hospitalized Delirium Are Associated With Decreased Access to Kidney Transplantation and Increased Risk of Waitlist Mortality
Background: Kidney transplant (KT) candidates often experience hospitalizations, increasing their delirium risk. Hospitalizations and delirium are associated with worse post‐KT outcomes, yet their relationship with pre‐KT outcomes is less clear. Pre‐KT delirium may worsen access to KT due to its negative impact on cognition and ability to maintain overall health.Methods: Using a prospective cohort of 2374 KT candidates evaluated at a single center (2009–2020), we abstracted hospitalizations and associated delirium records after listing via chart review. We evaluated associations between waitlist mortality and likelihood of KT with hospitalizations and hospitalized delirium using competing risk models and tested whether associations differed by gerontologic factors.Results: During a median of 1.8 years after listing, 735 (31.0%) candidates had ≥1 hospitalizations. Candidates with less education, frailty, depressive symptoms, and lower extremity function impairment were more likely to be hospitalized. Hospitalization was associated with higher waitlist mortality (aSHR = 3.65, 95% CI: 2.99–4.45) and a lower likelihood of KT (aSHR = 0.74, 95% CI: 0.66–0.84). Among candidates who were hospitalized, 80 (11%) had ≥1 delirium episodes. Candidates who were older, frail, and impaired in lower extremity function were more likely to have delirium, which was associated with higher waitlist mortality (aSHR = 4.87, 95% CI: 3.42–6.93) and a lower likelihood of KT (aSHR = 0.45, 95% CI: 0.27–0.74). The association between hospitalization and KT differed by candidate age (pinteraction < 0.001), with those aged ≥65 having a 61% lower likelihood of KT.Conclusion: Hospitalization and delirium are associated with worse pre‐KT outcomes and have serious implications on candidates’ access to KT. Providers should work to reduce preventable instances of delirium.
- 5 November 2024
- Published by Wiley in Clinical Transplantation
- Vol. 38 (11) , e70018
Hospitalization and Hospitalized Delirium Are Associated With Decreased Access to Kidney Transplantation and Increased Risk of Waitlist Mortality
Background: Kidney transplant (KT) candidates often experience hospitalizations, increasing their delirium risk. Hospitalizations and delirium are associated with worse post‐KT outcomes, yet their relationship with pre‐KT outcomes is less clear. Pre‐KT delirium may worsen access to KT due to its negative impact on cognition and ability to maintain overall health.Methods: Using a prospective cohort of 2374 KT candidates evaluated at a single center (2009–2020), we abstracted hospitalizations and associated delirium records after listing via chart review. We evaluated associations between waitlist mortality and likelihood of KT with hospitalizations and hospitalized delirium using competing risk models and tested whether associations differed by gerontologic factors.Results: During a median of 1.8 years after listing, 735 (31.0%) candidates had ≥1 hospitalizations. Candidates with less education, frailty, depressive symptoms, and lower extremity function impairment were more likely to be hospitalized. Hospitalization was associated with higher waitlist mortality (aSHR = 3.65, 95% CI: 2.99–4.45) and a lower likelihood of KT (aSHR = 0.74, 95% CI: 0.66–0.84). Among candidates who were hospitalized, 80 (11%) had ≥1 delirium episodes. Candidates who were older, frail, and impaired in lower extremity function were more likely to have delirium, which was associated with higher waitlist mortality (aSHR = 4.87, 95% CI: 3.42–6.93) and a lower likelihood of KT (aSHR = 0.45, 95% CI: 0.27–0.74). The association between hospitalization and KT differed by candidate age (pinteraction < 0.001), with those aged ≥65 having a 61% lower likelihood of KT.Conclusion: Hospitalization and delirium are associated with worse pre‐KT outcomes and have serious implications on candidates’ access to KT. Providers should work to reduce preventable instances of delirium.
- 20 October 2024
- Published by Wiley in Clinical Transplantation
- Vol. 38 (10) , e70001
Dietary Restriction, Socioeconomic Factors, Access to Kidney Transplantation, and Waitlist Mortality
Introduction: Dietary restrictions for patients with end‐stage kidney disease (ESKD) are burdensome. Kidney transplantation (KT) candidates who lack neighborhood resources and are burdened by dietary restrictions may have decreased access to KT.Methods: In our two‐center prospective cohort study (2014–2023), 2471 ESKD patients who were evaluated for KT (candidates) reported their perceived burden of dietary restrictions (not at all, somewhat/moderately, or extremely bothered). Neighborhood‐level socioeconomic factors were derived from residential ZIP codes. We quantified the association of perceived burden of the dietary restrictions with a chance of listing using Cox models and risk of waitlist mortality using competing risks models. Then we tested whether these associations differed by neighborhood‐level socioeconomic factors.Results: At evaluation, 18% of KT candidates felt extremely bothered by dietary restrictions. Those who felt extremely bothered were less likely to be listed for KT (adjusted hazard ratio [aHR] = 0.75, 95% confidence interval [CI]: 0.64–0.87); this association did not differ by neighborhood‐level socioeconomic factors. Overall, the burden of dietary restrictions was not associated with waitlist mortality (p = 0.62). However, among candidates living in high food insecurity neighborhoods, those who felt extremely bothered had higher waitlist mortality (adjusted subhazard ratio [aSHR] = 2.07, 95% CI: 1.14–3.75, p[interaction] = 0.02). The association between dietary burden and waitlist mortality did not differ by neighborhood‐level healthy food access.Conclusion: The perceived burden of dietary restrictions is associated with a lower chance of listing for KT, and higher waitlist mortality only among candidates residing in neighborhoods with high food insecurity. Transplant centers should identify vulnerable patients and support them with nutrition education and access to food assistance programs.
- 20 October 2024
- Published by Wiley in Clinical Transplantation
- Vol. 38 (10) , e70001
Dietary Restriction, Socioeconomic Factors, Access to Kidney Transplantation, and Waitlist Mortality
Introduction: Dietary restrictions for patients with end‐stage kidney disease (ESKD) are burdensome. Kidney transplantation (KT) candidates who lack neighborhood resources and are burdened by dietary restrictions may have decreased access to KT.Methods: In our two‐center prospective cohort study (2014–2023), 2471 ESKD patients who were evaluated for KT (candidates) reported their perceived burden of dietary restrictions (not at all, somewhat/moderately, or extremely bothered). Neighborhood‐level socioeconomic factors were derived from residential ZIP codes. We quantified the association of perceived burden of the dietary restrictions with a chance of listing using Cox models and risk of waitlist mortality using competing risks models. Then we tested whether these associations differed by neighborhood‐level socioeconomic factors.Results: At evaluation, 18% of KT candidates felt extremely bothered by dietary restrictions. Those who felt extremely bothered were less likely to be listed for KT (adjusted hazard ratio [aHR] = 0.75, 95% confidence interval [CI]: 0.64–0.87); this association did not differ by neighborhood‐level socioeconomic factors. Overall, the burden of dietary restrictions was not associated with waitlist mortality (p = 0.62). However, among candidates living in high food insecurity neighborhoods, those who felt extremely bothered had higher waitlist mortality (adjusted subhazard ratio [aSHR] = 2.07, 95% CI: 1.14–3.75, p[interaction] = 0.02). The association between dietary burden and waitlist mortality did not differ by neighborhood‐level healthy food access.Conclusion: The perceived burden of dietary restrictions is associated with a lower chance of listing for KT, and higher waitlist mortality only among candidates residing in neighborhoods with high food insecurity. Transplant centers should identify vulnerable patients and support them with nutrition education and access to food assistance programs.